Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

AVEN anticorps (C-Term)

AVEN Reactivité: Humain, Souris, Rat WB, IHC (p) Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN541412
  • Antigène Voir toutes AVEN Anticorps
    AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
    Épitope
    • 15
    • 13
    • 8
    • 6
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 48
    • 13
    • 6
    • 3
    Humain, Souris, Rat
    Hôte
    • 46
    • 2
    Lapin
    Clonalité
    • 45
    • 2
    Polyclonal
    Conjugué
    • 17
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp AVEN est non-conjugé
    Application
    • 41
    • 22
    • 13
    • 13
    • 7
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Fonction
    Rabbit polyclonal antibody raised against synthetic peptide of AVEN.
     Réactivité croisée
    Humain, Souris, Rat
    Immunogène
    A synthetic peptide corresponding to C-terminus of human AVEN.
    Top Product
    Discover our top product AVEN Anticorps primaire
  • Indications d'application
    Western Blot (0.5-1 μg/mL)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In PBS (0.02 % sodium azide)
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C for three months. For long term storage store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Paydas, Tanriverdi, Yavuz, Disel, Sahin, Burgut: "Survivin and aven: two distinct antiapoptotic signals in acute leukemias." dans: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 14, Issue 7, pp. 1045-50, (2003) (PubMed).

    Lockshin, Osborne, Zakeri: "Cell death in the third millennium." dans: Cell death and differentiation, Vol. 7, Issue 1, pp. 2-7, (2000) (PubMed).

    Chau, Cheng, Kerr, Hardwick: "Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1." dans: Molecular cell, Vol. 6, Issue 1, pp. 31-40, (2000) (PubMed).

  • Antigène
    AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
    Autre désignation
    AVEN (AVEN Produits)
    Synonymes
    anticorps AVEN, anticorps pdcd12, anticorps aven, anticorps wu:fc08c09, anticorps si:ch211-150c22.4, anticorps PDCD12, anticorps 1700013A01Rik, anticorps 1700056A21Rik, anticorps mAven-L, anticorps mAven-S, anticorps apoptosis and caspase activation inhibitor, anticorps apoptosis, caspase activation inhibitor L homeolog, anticorps apoptosis, caspase activation inhibitor, anticorps Aven, anticorps AVEN, anticorps aven.L, anticorps aven
    ID gène
    57099
Vous êtes ici:
Support technique